Cumberland Pharmaceuticals (CPIX) Assets Average (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Assets Average of $73.9 million for Q1 2026, up 3.57% sequentially from $71.4 million in Q4 2025, and up 1.58% YoY from $72.8 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Assets Average (2011 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Assets Average for 16 years, with the latest figure at $73.9 million in Q1 2026.
- Quarterly Assets Average rose 1.58% year-over-year to $73.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.9 million (up 1.58% YoY) and the FY2025 annual result came in at $76.2 million, down 3.15% from the prior year.
- Assets Average grew to $73.9 million in Q1 2026 per CPIX's latest filing, from $71.4 million in the prior quarter.
- Over five years, Assets Average peaked at $94.6 million in Q2 2022 and troughed at $66.9 million in Q3 2025.
- A 5-year average of $81.9 million and a median of $81.6 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2025: Assets Average increased 6.78% in 2022, then declined 13.86% in 2025.
- Over 5 years, Assets Average stood at $91.9 million in 2022, then dropped by 7.72% to $84.8 million in 2023, then retreated by 10.14% to $76.2 million in 2024, then dropped by 6.31% to $71.4 million in 2025, then increased by 3.57% to $73.9 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $73.9 million, $71.4 million, and $66.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Cumberland Pharmaceuticals | 117.68 Mn | 113.82 Mn | - | 66.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.94 Mn |
| Mar 31, 2026 | 73.91 Mn |
| Dec 31, 2025 | 71.36 Mn |
| Sep 30, 2025 | 66.90 Mn |
| Jun 30, 2025 | 68.92 Mn |
| Mar 31, 2025 | 72.76 Mn |
| Dec 31, 2024 | 76.17 Mn |
| Sep 30, 2024 | 77.63 Mn |
| Jun 30, 2024 | 80.01 Mn |
| Mar 31, 2024 | 81.64 Mn |
| Dec 31, 2023 | 84.76 Mn |
| Sep 30, 2023 | 88.56 Mn |
| Jun 30, 2023 | 89.42 Mn |
| Mar 31, 2023 | 91.20 Mn |
| Dec 31, 2022 | 91.85 Mn |
| Sep 30, 2022 | 91.65 Mn |
| Jun 30, 2022 | 94.61 Mn |
| Mar 31, 2022 | 90.58 Mn |
| Dec 31, 2021 | 86.02 Mn |
| Sep 30, 2021 | 88.21 Mn |